Statement Of Cash Flows [Abstract]

BerGenBio - Filing #2615544

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for interest income
3,130,000 NOK
3,614,000 NOK
Adjustments for increase (decrease) in trade and other payables
3,270,000 NOK
11,982,000 NOK
Adjustments for depreciation expense
1,312,000 NOK
726,000 NOK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
70,000 NOK
40,760,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.